序号 |
标题 |
次数 |
作者 |
发布时间 |
84421 |
MPEG-SS-Silane 甲氧基聚乙二醇-二硫键-硅烷 |
86 |
zyl |
2024-11-27 |
84422 |
DOX-SS-MAL,阿霉素-双硫键-马来酰亚胺 |
94 |
zyl |
2024-11-27 |
84423 |
FITC-SS-FITC 荧光素-双硫键-荧光素 |
90 |
zyl |
2024-11-27 |
84424 |
DOTA缀合的α-黑素细胞刺激激素肽类似物 ; DOTA-α-MSH |
135 |
wyh |
2024-11-27 |
84425 |
DOTA-AE105 ; DOTA偶联AE105肽 |
157 |
wyh |
2024-11-27 |
84426 |
DOTA-PEG-CPNs ; DSPE-PEG-DOTA包裹共轭聚合物纳米粒子(CPNs) |
168 |
wyh |
2024-11-27 |
84427 |
DOTA-[Tyr3]奥曲肽;DOTA-[Tyr3] octreotate |
94 |
wyh |
2024-11-27 |
84428 |
α-芳基取代的GdDOTA衍生物 |
106 |
wyh |
2024-11-27 |
84429 |
DOTA-JR11 ; DOTA偶联生长抑素受体拮抗剂JR11 |
139 |
wyh |
2024-11-27 |
84430 |
DOTA-UTriMA-Lys-NLS |
71 |
wyh |
2024-11-27 |
84431 |
BCN-DOTA-GA;环辛烯连接的DOTA螯合剂 |
105 |
wyh |
2024-11-27 |
84432 |
DOTA-8-Aoc-BBN[7-14]NH2缀合物 |
91 |
wyh |
2024-11-27 |
84433 |
DOTA-Ahx-VGB3;DOTA-6-氨基己酸修饰靶向肽VGB3 |
188 |
wyh |
2024-11-27 |
84434 |
DOTA-FAPI-maleimide ;DOTA-FAPI-马来酰亚胺 |
95 |
wyh |
2024-11-27 |
84435 |
DOTA-Siglec-9 ;1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸缀合Siglec-9基序包含肽 |
117 |
wyh |
2024-11-27 |
84436 |
DOTA-嘌呤霉素;DOTA-puromycin |
83 |
wyh |
2024-11-27 |
84437 |
DOTA-Bn-硫脲-peg 4-硫脲-Bn-DOTA;DOTA-Bn-thiourea-PEG4-thiourea-Bn-DOTA |
103 |
wyh |
2024-11-27 |
84438 |
异硫氰基苄基—1,4,7,10—四氮杂环十二烷四乙酸;p-SCN-Bz-DOTA |
96 |
wyh |
2024-11-27 |
84439 |
多功能两亲性多臂星形嵌段聚合物,H40-PCL-b-P,(OEGMA-Gd-FA) |
142 |
wyh |
2024-11-27 |
84440 |
DOTA偶联小分子多肽[c(RGDyK)];DOTA-c(RGDyK) |
136 |
wyh |
2024-11-27 |
84441 |
Cu-p-SCN-Bn-DOTA-KLH;双功能螯合剂DOTA偶联KLH抗体 |
166 |
wyh |
2024-11-27 |
84442 |
DOTA-Bz-RGD tetramer;DOTA偶联苄基修饰RGD四聚体 |
96 |
wyh |
2024-11-27 |
84443 |
DOTA-sst2-ANT;DOTA偶联受体拮抗剂 |
67 |
wyh |
2024-11-27 |
84444 |
二肽联接的二倍体造影剂配体 ;{HO-GK-(DOTA)2} |
94 |
wyh |
2024-11-27 |
84445 |
DOTA-Cys-ZHER2:342;大环DOTA修饰Z HER2:342-半胱氨酸 |
102 |
wyh |
2024-11-27 |
84446 |
DOTA-[Tyr3]-Octreotide 奥曲肽PET探针前体 |
128 |
zcy |
2024-11-26 |
84447 |
Gd-DOTA-HCBP;用于核磁共振成像(MRI)的多肽探针 |
146 |
zcy |
2024-11-26 |
84448 |
204318-14-9,Edotreotide,奥曲肽的多肽,DOTA大环化合物 |
98 |
zcy |
2024-11-26 |
84449 |
1610950-41-8,DOTA-甲基四嗪 |
111 |
zcy |
2024-11-26 |
84450 |
1189194-65-7,DOTA-CH2-Alkynyl (TFA salt) |
72 |
zcy |
2024-11-26 |
84451 |
177943-89-4,DOTATATE,DOTA-3-酪氨酰基-奥曲肽 |
98 |
zcy |
2024-11-26 |
84452 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2;肽类配体 |
137 |
zcy |
2024-11-26 |
84453 |
DOTA-Octreotide,DOTA-奥曲肽 |
93 |
zcy |
2024-11-26 |
84454 |
DOTA-(酪氨酸3)-奥曲肽,DOTA-[Tyr3]-Octreotide,204318-14-9 |
115 |
zcy |
2024-11-26 |
84455 |
PSMA I&T,2192281-54-0 |
98 |
zcy |
2024-11-26 |
84456 |
DOTA-E[cyclo(RGDfK)2] 螯合物前体多肽 |
78 |
zcy |
2024-11-26 |
84457 |
204318-14-9,DOTA-(酪氨酸3)-奥曲肽 |
76 |
zcy |
2024-11-26 |
84458 |
大环配体奥曲肽,Dotatate,DOTA-奥曲肽 |
131 |
zcy |
2024-11-26 |
84459 |
NOTA-8-AOC-BBN(7-14)NH2 ;1,4,7-三氮杂环壬烷-1,4,7-三乙酸-8-氨基辛酸-铃蟾肽 |
144 |
kx |
2024-11-26 |
84460 |
NOTA-Arg-Gly-Asp , NOTA-RGD ,环状螯合剂NOTA偶联多肽RGD |
146 |
kx |
2024-11-26 |
84461 |
NOTA-糖N-乙酰神经氨酸 ,NOTA-Neu5Ac |
108 |
kx |
2024-11-26 |
84462 |
DOTA-[Tyr3]-Octreotide(CAS:204318-14-9),DOTA-(酪氨酸3)-奥曲肽,依多曲肽 |
152 |
zcy |
2024-11-26 |
84463 |
DOTA-3-酪氨酰基-奥曲肽(DOTA-3-tyrosinyl-octreotide) |
96 |
zcy |
2024-11-26 |
84464 |
NOTA-RGD-GE11 ,异二聚体肽缀合NOTA大环配体 |
129 |
kx |
2024-11-26 |
84465 |
DOTA-3-酪氨酰基-奥曲肽,DOTA-(Tyr3)-Octreotate |
97 |
zcy |
2024-11-26 |